‘The family of a six-year-old girl with cystic fibrosis who was denied funding for a breakthrough drug which could extend her life has launched a judicial review against the NHS.’
The Independent, 14th November 2018
Source: www.independent.co.uk
‘The UK government should consider changing patent law to incentivise major pharmaceutical companies to develop new antibiotics to address the “grave threat to health” posed by antimicrobial resistance (AMR), a committee of MPs has said.’
OUT-LAW.com, 1st November 2018
Source: www.out-law.com
‘Bayer Plc v NHS Darlington Clinical Commissioning Groups (CCG) and others [2018] EWHC 2465 (Admin). This judicial review concerned whether it was lawful for NHS clinical commissioning groups to adopt a policy for offering the drug Avastin to patients suffering from “wet” (or neo-vascular) age-related macular degeneration (AMD). Avastin, although not licensed for ophthalmic use, at £28 per injection is significantly cheaper than the licensed alternatives (£816 and £551 respectively per injection). The Royal College of Ophthalmologists has estimated that the NHS-wide saving of switching to Avastin was at least £102 million p.a.’
UK Human Rights Blog, 4th October 2018
Source: ukhumanrightsblog.com
‘The NHS has won a landmark battle against drug giants paving the way for the health service to save millions by prescribing cheaper medicine.’
Daily Telegraph, 21st September 2018
Source: www.telegraph.co.uk
‘The health care regulator is calling for greater powers to protect patients from online GPs after a struck-off doctor was discovered using a loophole to prescribe “unsafe” drugs.’
Daily Telegraph, 6th August 2018
Source: www.telegraph.co.uk
‘Currently, the law states that all abortion pills must be taken in a clinic or hospital – meaning some women end up having an abortion on public transport, or while driving home.’
Rights Info, 31st July 2018
Source: rightsinfo.org
‘Cases of Billy Caldwell and Alfie Dingley, who have severe epilepsy, along with lobbying, prompted change.’
The Guardian, 26th July 2018
Source: www.theguardian.com
‘The Home Secretary today announced a review into the scheduling of cannabis for medicinal purposes.’
Home Office, 19th June 2018
Source: www.gov.uk/home-office
‘The government has said it will review the use of medicinal cannabis, although recreational usage will still be illegal.’
BBC News, 19th June 2018
Source: www.bbc.co.uk
‘A four-year inquiry into the deaths of hundreds of elderly people who were routinely prescribed opioid drugs is expected to say that blame lies not just with the doctor involved but also those who worked with her, failed to monitor her and who failed to investigate – including the government.’
The Guardian, 20th June 2018
Source: www.theguardian.com
‘Private Client analysis: Alex Ruck Keene, barrister, of 39 Essex Chambers, examines the decision of the Court of Protection in Re AB [2016] EWCOP 66 to approve deceiving a person lacking mental capacity in order to administer her medication.’
Family Law, 19th April 2018
Source: www.familylaw.co.uk
‘Manufacturers of branded medicines face new statutory controls on the cost of their drugs to the NHS in the UK from 1 April.’
OUT-LAW.com, 13th March 2018
Source: www.out-law.com
‘Daptomycin is an antibiotic used to treat systemic and life-threatening infections caused by multiple drug resistant bacteria. Its effectiveness depends on its purity. The invention for which the patent in suit was granted was a way of purifying the antibiotic. In Hospira UK Ltd v Cubist Pharmaceuticals LLC [2016] EWHC 1285 (Pat) (10 June 2016), Hospira UK Ltd, (a British subsidiary of Pfizer) sought the revocation of that patent. Mr Justice Henry Carr found that the patent was invalid and ordered its revocation. Cubist Pharmaceuticals LLC (a subsidiary of Merck & Co.) appealed against that judgment and order in Hospira UK Ltd v Cubist Pharmaceuticals LLC [2018] EWCA Civ 12 (18 Jan 2018).’
NIPC Law, 24th January 2018
Source: nipclaw.blogspot.co.uk
‘Two drug giants are threatening to take the NHS to court for plans to offer patients cheap treatment to prevent blindness.’
Daily Telegraph, 1st November 2017
Source: www.telegraph.co.uk
‘Body modification artists have been exposed carrying out illegal and potentially dangerous tongue splitting procedures.’
BBC News, 9th October 2017
Source: www.bbc.co.uk
‘Medical experts were “complicit” in allowing thousands of children to suffer deformity after resisting warnings on epilepsy drugs, campaigners have said.’
Daily Telegraph, 26th September 2017
Source: www.telegraph.co.uk
‘Laughing gas could still be legal after a judge dismissed a case, saying the drug is not covered by a law which bans “legal highs”.’
The Independent, 31st August 2017
Source: www.independent.co.uk
‘Rosalind English discusses with David Hart QC a recent challenge to the refusal by the NHS to fund a specialist drug for a child suffering from a metabolic condition.’
Law Pod UK, 17th August 2017
Source: audioboom.com
‘The family of a seven-year-old boy whose condition could cause brain damage have won a High Court challenge over an NHS decision not to fund a life-changing drug.’
BBC News, 8th August 2017
Source: www.bbc.co.uk
‘Supreme Court (Lords Neuberger, Mance, Clarke, Sumption and Hodge) Eli Lilly v Actavis UK Ltd and others [2017] UKSC 48 (12 July 2017)
What the Appeal was about
The pharmaceutical company Eli Lilly and Co (“Lilly”) has developed a drug called pemetrexed which it markets under the brand name Alimta for the treatment of various types of cancer. Used on its own, pemetrexed has unpleasant side effects that can sometimes be fatal but these can be avoided when it is administered as a compound called pemetrexed disodium in combination with vitamin B12.’
NIPC Law, 13th July 2017
Source: nipclaw.blogspot.co.uk
© Inner Temple Library 2024